Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

MARICO LTD. - 531642 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI Listing Regulations, please find enclosed the newspaper extract of the un-audited consolidated financial results of the Company for the quarter ended June 30, 2023, approved by the Bard of Directors at its meeting held on July 28, 2023 and published in Financial Express and The Free Press Journal (English daily) and Navshakti (Marathi daily) today i.e. on July 29, 2023. The same is being made available on the website of the Company.
29-07-2023
Bigul

MARICO LTD. - 531642 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings conference call held on Friday, July 28, 2023 on the un-audited financial results and operations of the Company for the quarter ended June 30, 2023, is available on the Company's website. Further, the transcript of the aforesaid conference call will be intimated to the stock exchanges subsequently and published on the Company's website under the aforesaid link. This is for your information and records.
28-07-2023

Marico Consolidated June 2023 Net Sales at Rs 2,477.00 crore, down 3.17% Y-o-Y
28-07-2023
Bigul

Q1FY24 Quarterly Result Announced for Marico Ltd.

 Personal products company Marico announced Q1FY24 results: Revenue from operations of Rs 2,477 crore, down 3% YoY EBITDA of Rs 574 crore, up 9% YoY EBITDA margin of 23.2%, Up 253 bps Profit after tax (excl. one-offs) of Rs 416 crore, up 12% YoY Domestic volume growth (%) of 3% International business (% CCG) of 9% Domestic revenue was at Rs 1,827 crore, down 5% on a YoY basis Saugata Gupta, MD & CEO, commented, “The year has started on a mixed note with domestic volume growth marred by one-offs, while the international business was resilient in a challenging environment. However, we remain confident of an improving trajectory of growth in the domestic business and sustained momentum in the international business. We have delivered robust margin expansion on the back of a softening input cost environment and expect to deliver healthy profitability this year. We will continue to drive sustainable and profitable volume-led growth by maintaining focus on our strategic priorities of diversification, go-to-market transformation, digital capability building, and fostering an inclusive organizational culture.” Result PDF
28-07-2023
Bigul

MARICO LTD. - 531642 - Information Update For The Quarter Ended June 30, 2023

 Information Update for the quarter ended June 30, 2023.
28-07-2023
Bigul

MARICO LTD. - 531642 - Approval Of The Un-Audited Standalone And Consolidated Financial Results Of Marico Limited For The Quarter Ended June 30, 2023

 Approval of the Un-audited standalone and consolidated financial results of Marico Limited for the quarter ended June 30, 2023.
28-07-2023
Bigul

MARICO LTD. - 531642 - Board Meeting Outcome for Outcome Of The Board Meeting Held On July 28, 2023

 Outcome of the Board meeting held on July 28, 2023
28-07-2023

Morgan Stanley upgrades Marico to overweight after acquisition of Satiya

 Satiya Nutraceuticals owns the brand Plix, which has a product range across weight management, hair and beauty, sleep and nutrition categories, said the company in an exchange filing dated July 26.
27-07-2023
Bigul

MARICO LTD. - 531642 - Announcement under Regulation 30 (LODR)-Acquisition

 This is to inform you that Marico Limited ("the Company") has entered into definitive agreements today to acquire upto 58% of the paid-up share capital of Satiya Nutraceuticals Private Limited ("Satiya Nutraceuticals"), on a fully diluted basis, the company which owns the brand "the Plant Fix - Plix" - a leading plant based nutrition brand with a strong presence in the rapidly growing health and wellness segment. As part of the transaction, the Company has acquired 32.75% stake in Satiya Nutraceuticals on a fully diluted basis and requisite majority control over its Board composition/ total voting rights on July 26, 2023, and accordingly it has become a subsidiary of the Company. The acquisition of remaining stake of 25.25% on a fully dilutes basis, will be completed in tranches by May, 2025, subject to terms and conditions of the definitive agreements. This is for your information and records.
26-07-2023
Bigul

MARICO LTD. - 531642 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform you that the Company will hold an investor/analyst conference call on Friday, July 28, 2023 at 6:00 p.m. (IST). During the call, the Management will comment on the financial results and operations for the quarter ended June 30, 2023.
20-07-2023
Next Page
Close

Let's Open Free Demat Account